MedTrace Logo

Fluids Affecting Bladder Urgency and Lower Urinary Symptoms

NCT03625492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2019-11-14

No results posted yet for this study

Summary

This study evaluates whether eliminating certain ingredients (caffeine, alcohol, artificial sweeteners, acidic juices) consumed in beverages reduces bladder symptoms of urinary frequency and urgency. Women with overactive bladder will be recruited. Half of these women will receive instructions to replace beverages containing these ingredients with beverages such as water or milk. The other half of participants will receive instructions on following the United States Department of Agriculture guidelines on healthy eating.

Conditions

  • Overactive Bladder
  • Urinary Urgency
  • Urinary Bladder, Overactive
  • Urinary Incontinence, Urge
  • Caffeine
  • Alcohol Drinking
  • Lower Urinary Tract Symptoms

Interventions

BEHAVIORAL

Reducing Potentially Irritating Beverages

This group will receive a 7 minute video teaching participants to replace beverages that include caffeine, alcohol, artificial sweeteners, or acidic juices with equal volume intake of water, milk, or other beverages that do not have these ingredients in them.

BEHAVIORAL

Adopting the USDA Healthy Eating Habits

This group will receive a 7 minute video teaching them the USDA guidelines for healthy eating.

Sponsors & Collaborators

  • Blue Cross Blue Shield of Michigan Foundation

    collaborator OTHER

  • Arbor Research Collaborative for Health

    collaborator OTHER

  • University of Michigan

    lead OTHER

Principal Investigators

  • Janis M Miller, PhD · University of Michigan

  • Megan O Schimpf, MD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-07
Primary Completion
2019-09-17
Completion
2019-09-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03625492 on ClinicalTrials.gov